Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes

Victoria Campuzano, Laura Montermini, Yves Lutz, Lidia Cova, Colette Hindelang, Sarn Jiralerspong, Yvon Trottier, Stephen J. Kish, Baptiste Faucheux, Paul Trouillas, François J. Authier, Alexandra Dürr, Jean Louis Mandel, Angelo Vescovi, Massimo Pandolfo, Michel Koenig

Research output: Contribution to journalArticlepeer-review

649 Scopus citations


Friedreich ataxia is a progressive neurodegenerative disorder caused by loss of function mutations in the frataxin gene. In order to unravel frataxin function we developed monoclonal antibodies raised against different regions of the protein. These antibodies detect a processed 18 kDa protein in various human and mouse tissues and cell lines that is severely reduced in Friedreich ataxia patients. By immunocytofluorescence and immunocytoelectron microscopy we show that frataxin is located in mitochondria, associated with the mitochondrial membranes and crests. Analysis of cellular localization of various truncated forms of frataxin expressed in cultured cells and evidence of removal of an N-terminal epitope during protein maturation demonstrated that the mitochondrial targetting sequence is encoded by the first 20 amino acids. Given the shared clinical features between Friedreich ataxia, vitamin E deficiency and some mitochondriopathies, our data suggest that a reduction in frataxin results in oxidative damage.

Original languageEnglish (US)
Pages (from-to)1771-1780
Number of pages10
JournalHuman Molecular Genetics
Issue number11
StatePublished - Oct 1997

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes'. Together they form a unique fingerprint.

Cite this